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Chronic Granulomatous Disease (CGD) is an inherited
deficiency which results from the absence or dysfunction of
nicotinamide adenine dinucleotide phosphate (NADPH)
oxidase subunits in phagocytic cells. This condition is
usually diagnosed in early childhood and presents with
recurrent infections at epithelial surfaces such as the
skin, lungs, and gut. We present a case of CGD which
was diagnosed late in adulthood.
Case presentation
A forty-four year old male was admitted to hospital with
fever, testicular pain and an acute onset of swelling of
his penis and scrotum.
His past history was significant for Crohn’s disease
diagnosed at age sixteen; stable on treatment with
mesalamine (AsacolW). He also had recurrent soft tissue
infections of his penis and/or scrotum since childhood,
approximately 2 or 3 in total, to his recollection. There was
no history of abscesses or sexually transmitted infections.
However, the patient did complain of frequent upper
respiratory tract infections each winter. He had no family
history of primary immunodeficiency disease.
During admission, he was assessed by urology and
general surgery. Both confirmed the absence of any
anatomic abnormalities. An immunologist suggested work
up for immunodeficiency. Basic laboratory investigations
were normal, with a white blood cell count of 7.8 × 109 L.
C-reactive protein was elevated at 69.7 mg/L. Both his
rheumatoid factor and HIV testing were negative. Serum
levels of IgA, IgM and IgG levels were all within normal
limits (Table 1 reports full details of his immunology
investigations) Blood cultures were negative. A CT* Correspondence: ellisa@queensu.ca
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reproduction in any medium, provided the orscan of the chest was normal. CT scan of the abdomen
and pelvis revealed no subcutaneous air to suggest a
necrotizing infection.
Quantitative dihydrorhodamine (DHR)123 flow cytome-
try assay revealed the complete absence of an oxidative
burst response; this was confirmed three times. This was
suggestive of a neutrophil NADPH oxidase deficiency
associated with CGD.
The patient was treated with intravenous cefazolin and
metronidazole and discharged home on clindamycin.
His cellulitis resolved within weeks, but he experienced
a recurrence approximately 6 months later. He was
started on trimethoprim-sulfamethoxazole (TMP-SMX),
amoxicillin, and itraconazole as prophylactic therapy to
prevent future infections. He was assessed by the Infectious
Disease service, who simplified his prophylactic regimen to
TMP-SMX 160/800 q Mon/Wed/Fri and Penicillin V K
300mg OD based on risk assessment and previous infective
patterns. Interferon-gamma was considered, but based on
restricted availability at the time and his relatively stable
clinical course to date, we elected to pursue antibiotic
prophylaxis and active surveillance alone.
Genetic testing, performed by the Hospital for Sick
Children in Toronto, confirmed a diagnosis of CGD and
revealed a homozygous mutation in the NCFI gene
(P47). It was recommended that directly family members
receive DHR flow cytometry screening but this was
declined.Discussion
CGD is a rare disorder with an approximate incidence of
1 in 200,000 births [1]. A mutation in one of four protein
subunits of the NADPH oxidase complex (gp91-, p22-,
p47-, p67-phox) result in CGD. The NADPH oxidase en-
zyme complex is responsible for production of superoxide
anions required for a cellular respiratory burst. Patients
deficient in the NADPH oxidase enzyme become suscep-
tible to recurrent life-threatening infections by a spectrumLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Results of Immunologic Investigations
Parameter Value Reference range
WBC 7.8 × 109/L 4.0 – 11.0 × 109/L
CD19 + 11% 4 – 26%
CD4+ 0.87 × 109/L 0.50 – 1.75 × 109/L
CD8+ 0.32 × 109/L 0.15 – 0.84 × 109/L
IgA 3.53 g/L 0.70 – 3.52 g/L
IgG 12.50 g/L 6.35 – 14.65 g/L
IgM 1.72 g/L 0.41 – 2.07 g/L
CGD Test Absence of Oxidative Burst Response
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Staphyloccocus spp [1]. There are 410 known mutations
of the 4 affected genes with 76% related to a mutation of
gp91-phox, the x-linked recessive form. The p47-phox
mutation occurs in 18%, while the p67 and p22 mutations
are less common (4 and 3%, respectively) [1].
The most common infections in CGD include pneumo-
nia, abscess and suppurative adenitis (79%, 68%, and 53%
respectively), while cellulitis occurs in only 10% [1]. CGD
can also present with a granulomatous colitis mimicking
Crohn’s disease in 17% [1].
CGD patients can be vaccinated with measles, varicella
and annual influenzae, but BCG should be avoided
because of the risk of developing disseminated BCG-osis
[2]. Prophylactic antibiotics and anti-fungal agents such
as trimethoprim-sulfamethoxazole and itraconazole have
been found in small studies to reduce rates of infections,
surgical interventions and hospitalization [3,4]. Prophylactic
IFN-γ given thrice weekly may reduce the risk of serious
infections [5]. Bone marrow transplantation provides
definitive treatment but is reserved for the most severe
cases and gene therapy with retroviral vectors may be a
promising solution in the future [6].
CGD is usually diagnosed in childhood. The mean age of
diagnosis for the x-linked recessive form is 3 years of age
while the autosomal recessive forms are diagnosed at 7.8
years of age [1]. A small number of CGD cases have been
diagnosed in adulthood beyond the fourth decade [7-10];
the oldest case report identified in the English language
literature was of a male diagnosed at 69 years of age [11].
Conclusions
In summary, we present a patient who was diagnosed with
CGD in adulthood with manifestations limited to recurrent
scrotal cellulitis and a granulomatous colitis, which was ini-
tially misdiagnosed as Crohn’s disease. Adults with a history
of recurrent infections, particularly in atypical anatomic
locations, in the absence of obvious secondary immuno-
deficient states (e.g. diabetes mellitus, corticosteroid use)
should prompt an evaluation for underlying immunodefi-
ciency, regardless of the age at presentation.Consent
Written informed consent was obtained from the patient
for publication of this case report. A copy of the written
consent is available for review by the Editor-in-Chief of
this journal.
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